ACIR
@acir_org
Accelerating Cancer Immunotherapy Research. A free weekly digest of the latest findings in the field. We also make cool images :) Listen to @ImmunoTalks.
ID: 875012589985640450
http://ACIR.org 14-06-2017 15:30:33
4,4K Tweet
2,2K Takipçi
1,1K Takip Edilen
Gurrea‐Rubio et al. showed prolonged survival of SCID mice bearing s.c. human breast or prostate tumors that were infused intratumorally with human lymphocytes and treated with the IgG1 mAb UMCD6, specific for human CD6 [...] bit.ly/3HXy4ID Mikel Gurrea-Rubio U-M Department of Internal Medicine
![Gurrea‐Rubio et al. showed prolonged survival of SCID mice bearing s.c. human breast or prostate tumors that were infused intratumorally with human lymphocytes and treated with the IgG1 mAb UMCD6, specific for human CD6 [...] bit.ly/3HXy4ID <a href="/GurreaMikel/">Mikel Gurrea-Rubio</a> <a href="/UMIntMed/">U-M Department of Internal Medicine</a>](https://pbs.twimg.com/media/GGUOfyqXcAAWrO_.jpg "ACIR (@acir_org) on Twitter photo Gurrea‐Rubio et al. showed prolonged survival of SCID mice bearing s.c. human breast or prostate tumors that were infused intratumorally with human lymphocytes and treated with the IgG1 mAb UMCD6, specific for human CD6 [...] bit.ly/3HXy4ID <a href=\"/GurreaMikel/\">Mikel Gurrea-Rubio</a> <a href=\"/UMIntMed/\">U-M Department of Internal Medicine</a>")